Weighted Average Number of Shares Outstanding, Diluted of ProPhase Labs, Inc. from 2010 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
ProPhase Labs, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and change rate from 2010 to Q3 2025.
  • ProPhase Labs, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending 30 Sep 2025 was 41.5M shares, a 118% increase year-over-year.
  • ProPhase Labs, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 20.5M shares, a 18.9% increase from 2023.
  • ProPhase Labs, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 17.2M shares, a 7.74% decline from 2022.
  • ProPhase Labs, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 18.7M shares, a 1.4% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Change (%)

ProPhase Labs, Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 41.5M +22.5M +118% 01 Jul 2025 30 Sep 2025 10-Q 19 Nov 2025
Q2 2025 41.5M +22.7M +120% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025
Q1 2025 35.2M +18M +105% 01 Jan 2025 31 Mar 2025 10-Q 20 May 2025
Q4 2024 20.5M +3.26M +18.9% 01 Oct 2024 31 Dec 2024 10-K 01 Apr 2025
Q3 2024 19.1M +1.9M +11.1% 01 Jul 2024 30 Sep 2024 10-Q 19 Nov 2025
Q2 2024 18.9M +2.04M +12.1% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025
Q1 2024 17.2M -854K -4.73% 01 Jan 2024 31 Mar 2024 10-Q 20 May 2025
Q4 2023 17.2M -1.44M -7.74% 01 Oct 2023 31 Dec 2023 10-K 01 Apr 2025
Q3 2023 17.2M -3.07M -15.2% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 16.8M +16.8M 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2024
Q1 2023 18.1M +18M 01 Jan 2023 31 Mar 2023 10-Q 10 May 2024
Q4 2022 18.7M +258K +1.4% 01 Oct 2022 31 Dec 2022 10-K 29 Mar 2024
Q3 2022 20.2M +4.81M +31.1% 01 Jul 2022 30 Sep 2022 10-Q 13 Nov 2023
Q2 2022 19.3K* -15.1M 01 Apr 2022 30 Jun 2022 10-Q 11 Aug 2023
Q1 2022 18.7K* +540 01 Jan 2022 31 Mar 2022 10-Q 12 May 2023
Q4 2021 18.4M 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 15.4M 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 15.2M +15.1M 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2022
Q1 2021 18.2K* -11.6M 01 Jan 2021 31 Mar 2021 10-Q 13 May 2022
Q2 2020 11.6K* +58 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 11.6M +25K +0.22% 01 Jan 2020 31 Mar 2020 10-Q 14 May 2021
Q2 2019 11.6K* -11.3M 01 Apr 2019 30 Jun 2019 10-Q 11 Aug 2020
Q1 2019 11.6M +144K +1.26% 01 Jan 2019 31 Mar 2019 10-Q 14 May 2019
Q4 2018 11.4M -4.3M -27.4% 01 Oct 2018 31 Dec 2018 10-K 26 Mar 2019
Q3 2018 11.5K* -16M 01 Jul 2018 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 11.3M -5.6M -33.1% 01 Apr 2018 30 Jun 2018 10-Q 12 Aug 2019
Q1 2018 11.4M -6.36M -35.8% 01 Jan 2018 31 Mar 2018 10-Q 14 May 2019
Q4 2017 15.7M -1.39M -8.11% 01 Oct 2017 31 Dec 2017 10-K 26 Mar 2019
Q3 2017 16M -1.63M -9.28% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 16.9M -138K -0.81% 01 Apr 2017 30 Jun 2017 10-Q 20 Aug 2018
Q1 2017 17.8M +691K +4.05% 01 Jan 2017 31 Mar 2017 10-Q/A 20 Aug 2018
Q4 2016 17.1M +683K +4.17% 01 Oct 2016 31 Dec 2016 10-K/A 20 Aug 2018
Q3 2016 17.6M +628K +3.7% 01 Jul 2016 30 Sep 2016 10-Q/A 20 Aug 2018
Q2 2016 17.1M +1.06M +6.62% 01 Apr 2016 30 Jun 2016 10-Q/A 20 Aug 2018
Q1 2016 17.1M +1.19M +7.48% 01 Jan 2016 31 Mar 2016 10-Q/A 20 Aug 2018
Q4 2015 16.4M -375K -2.24% 01 Oct 2015 31 Dec 2015 10-K/A 20 Aug 2018
Q3 2015 17M +17M 01 Jul 2015 30 Sep 2015 10-Q 14 Nov 2016
Q2 2015 16M -924K -5.45% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016
Q1 2015 15.9M -577K -3.5% 01 Jan 2015 31 Mar 2015 10-Q 13 May 2016
Q4 2014 16.8M +497K +3.05% 01 Oct 2014 31 Dec 2014 10-K 29 Mar 2016
Q3 2014 18.2K* -16.3M 01 Jul 2014 30 Sep 2014 10-Q 13 Nov 2015
Q2 2014 16.9M +1.1M +6.94% 01 Apr 2014 30 Jun 2014 10-Q 12 Aug 2015
Q1 2014 16.5M +270K +1.67% 01 Jan 2014 31 Mar 2014 10-Q 13 May 2015
Q4 2013 16.3M +1.43M +9.65% 01 Oct 2013 31 Dec 2013 10-K 29 Mar 2016
Q3 2013 16.3M +1.33M +8.85% 01 Jul 2013 30 Sep 2013 10-Q 13 Nov 2014
Q2 2013 15.8M +1.01M +6.84% 01 Apr 2013 30 Jun 2013 10-Q 12 Aug 2014
Q1 2013 16.2M +1.4M +9.48% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 14.8M 01 Oct 2012 31 Dec 2012 10-K 27 Mar 2015
Q3 2012 15M -132K -0.87% 01 Jul 2012 30 Sep 2012 10-Q 13 Nov 2013
Q2 2012 14.8M -159K -1.06% 01 Apr 2012 30 Jun 2012 10-Q 13 Aug 2013
Q1 2012 14.8M 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q3 2011 15.1M 01 Jul 2011 30 Sep 2011 10-Q 14 Nov 2012
Q2 2011 15M 01 Apr 2011 30 Jun 2011 10-Q 13 Aug 2012

ProPhase Labs, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 20.5M +3.26M +18.9% 01 Jan 2024 31 Dec 2024 10-K 01 Apr 2025
2023 17.2M -1.44M -7.74% 01 Jan 2023 31 Dec 2023 10-K 01 Apr 2025
2022 18.7M +258K +1.4% 01 Jan 2022 31 Dec 2022 10-K 29 Mar 2024
2021 18.4M +6.8M +58.6% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 11.6M 01 Jan 2020 31 Dec 2020 10-K 31 Mar 2022
2018 11.4M -4.3M -27.4% 01 Jan 2018 31 Dec 2018 10-K 26 Mar 2019
2017 15.7M -1.39M -8.11% 01 Jan 2017 31 Dec 2017 10-K 26 Mar 2019
2016 17.1M +683K +4.17% 01 Jan 2016 31 Dec 2016 10-K/A 20 Aug 2018
2015 16.4M -375K -2.24% 01 Jan 2015 31 Dec 2015 10-K/A 20 Aug 2018
2014 16.8M +497K +3.05% 01 Jan 2014 31 Dec 2014 10-K 29 Mar 2016
2013 16.3M +1.43M +9.65% 01 Jan 2013 31 Dec 2013 10-K 29 Mar 2016
2012 14.8M +26K +0.18% 01 Jan 2012 31 Dec 2012 10-K 27 Mar 2015
2011 14.8M +532K +3.72% 01 Jan 2011 31 Dec 2011 10-K 27 Mar 2014
2010 14.3M 01 Jan 2010 31 Dec 2010 10-K 28 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.